Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 8NIH 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urinary Bladder Neoplasms 18Pancreatic Neoplasms 17Lung Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Biliary Tract Neoplasms 10Urethral Neoplasms 9Lymphoma 8Uterine Cervical Neoplasms 6Ovarian Neoplasms 6Gallbladder Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Large-Cell, Anaplastic 4Hodgkin Disease 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms 4Sarcoma 3Kidney Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Bile Duct Neoplasms 3Salivary Gland Neoplasms 2Recurrent Uterine Corpus Sarcoma 2Recurrence 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Immunoblastic Lymphadenopathy 2Fallopian Tube Neoplasms 2Adenocarcinoma of Lung 2

Interventions

Carboplatin 7Paclitaxel 6Radiotherapy 5Cisplatin 4Bevacizumab 4Cetuximab 2Amplified Fragment Length Polymorphism Analysis 2pegfilgrastim 1advexin 1Temozolomide 1Surgical Procedures, Operative 1Radiotherapy, Conformal 1Radiosurgery 1Polymerase Chain Reaction 1Pneumonectomy 1Pharmacogenomic Testing 1Pemetrexed 1Panitumumab 1Neoadjuvant Therapy 1Injections 1Immunohistochemistry 1Glutamic Acid 1Gene Expression Profiling 1Gemcitabine 1Filgrastim 1Etoposide 1Erlotinib Hydrochloride 1Early Intervention, Educational 1Docetaxel 1Chromosome Mapping 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma, Bronchiolo-Alveolar × Gemcitabine × Clear all
NCT00006004 2023-06-15

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡